Legend Biotech raises $150.5m in equity financing at $1.95b valuation

Legend Biotech raises $150.5m in equity financing at $1.95b valuation

03 April, 2020

cell therapy Genscript Biotech Legend Biotech Lilly Asia Ventures

Printed by Unregistered user on Tue, 22 Jul 2025 09:00:24 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Bankers brace for sharp slowdown in Asia IPOs on virus impact

CDH-backed biotech firm HitGen eyes $118m in STAR Market IPO

Read more from Greater China

Venture Capital

Startup funding in Greater China grows 13% in Q2 on Ximalaya’s $2.4b deal

Cannot rely solely on valuation metrics for AI investments: Cathay Innovation